Close this search box.

We are creating some awesome events for you. Kindly bear with us.

UOW Cancer Tech Research Receives Funding

Children with brain cancer are among those expected to benefit from two grants announced for University of Wollongong researchers.

The Cancer Institute NSW Fellowships – worth a combined value of over $1 million – will go to Dr Saree Alnaghy and Dr Linh Tran, both are from the Centre for Medical Radiation Physics (CMRP) and are also affiliated with the Illawarra Health and Medical Research Institute. Both fellowships run for three years.

Dr Tran is working on a new type of radiotherapy, called proton therapy, which can be ‘focused’ to stop at the site of the cancer tumour, without causing damage to surrounding normal tissue under the mentorship of Distinguished Professor Anatoly Rozenfeld.

Dr Alnaghy is developing a new imaging system for radiotherapy to better visualise soft tissue structures like tumours and critical organs under the mentorship of Senior Professor Peter Metcalfe.

He said that current problem is that it’s hard to aim the radiation beam during treatment and avoid healthy tissue before and during treatment. His team is, thus, looking into using a specialised spectral radiation detector that can measure the energy information of the X-rays that pass through the body.

“By analysing the energy, we can get more detailed information on the material it has passed through, giving us better soft-tissue contrast,” he said.

Better imagery leads to more accurate radiation delivery resulting in fewer side effects, more effective treatment, and less damage to healthy tissue. Dr Tran is also working on targeting tumours more directly but using an innovative treatment called proton therapy.

The CMRP team has invented a device called a “microdosimeter” which they wish to develop further to use in Australia’s first proton therapy facility, currently being developed in Adelaide, as well as in other locations around the world.

The invention represents a new paradigm that will provide maximum benefit to Australian cancer patients by minimising healthy tissue damage and maximising patient outcomes. Through a combination of innovation and creativity, the microdosimeter will have unique properties that permit the measurement of protons at clinically relevant high dose rates.

Dr Tran said the next generation of microdosimeter would also measure an important property called linear energy transfer, which determines the biological effect of the proton beam. She noted that this new treatment will be especially effective for patients with cancer tumours located next to other sensitive tissue or organs, such as the brain, the spine and the eye. It will be used where the side-effects of damaging healthy tissues is a major concern. This is particularly the case for cancers in children, and especially brain cancers, where the surrounding tissues are still critically developing.

The Cancer Institute NSW is a part of NSW Health and aims to end cancer by promoting early detection, cancer prevention, diagnosis treatment and care. The Research Fellowships are highly prestigious and competitive awards for researchers to build on their research capability and become leaders of their own research team.

The global cancer diagnostics market size was valued at US$17.2 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.5% from 2021 to 2026. The growth of the cancer diagnostics market is driven mainly by the increasing incidence of cancer and growth in the number of private diagnostic laboratories.

The number of private diagnostic centres is increasing across the globe as there is a rising demand for diagnostic imaging procedures and a growing burden on public hospitals due to the limited number of imaging modalities at their disposal.

By technology, the cancer diagnostics market is segmented into IVD testing, imaging-based and biopsy techniques. The IVD testing segment accounted for the largest market share in 2020. The large share of this segment can be attributed to the increasing incidence of cancer.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.